<!DOCTYPE html>
<!--[if lt IE 7 ]><html class="ie ie6" lang="en"> <![endif]-->
<!--[if IE 7 ]><html class="ie ie7" lang="en"> <![endif]-->
<!--[if IE 8 ]><html class="ie ie8" lang="en"> <![endif]-->
<!--[if (gte IE 9)|!(IE)]><!--><html lang="en"> <!--<![endif]-->
<head>

    <!-- Basic Page Needs
  ================================================== -->
	<meta charset="utf-8">
	<title>Times of Pshychiatry</title>
	<meta name="description" content=" |">
	<meta name="medekahealth" content="">
	
    <!-- Mobile Specific Metas
  ================================================== -->
	<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">
    
    <!-- CSS
  ================================================== -->
		<link rel="stylesheet" href="../css/style.css">
    <link rel="stylesheet" href="../css/responsive.css">
	
	<!--[if lt IE 8]>
       <div style=' clear: both; text-align:center; position: relative;'>
         <a href="http://windows.microsoft.com/en-US/internet-explorer/products/ie/home?ocid=ie6_countdown_bannercode">
           <img src="http://storage.ie6countdown.com/assets/100/images/banners/warning_bar_0000_us.jpg" border="0" height="42" width="820" alt="You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today." />
        </a>
      </div>
    <![endif]-->
    <!--[if lt IE 9]>
		<script src="js/html5.js"></script>
		<script src="js/css3-mediaqueries.js"></script>
	<![endif]-->
	
	<link href='./images/top.ico' rel='icon' type='image/x-icon'/>
<style type="text/css">
a:hover {
	cursor:pointer; 
}
</style>
<script type="text/javascript">

//SAG scroller demo #1:

var sagscroller1=new sagscroller({
	id:'mysagscroller',
	mode: 'manual' //<--no comma following last option
})

//SAG scroller demo #2:

var sagscroller2=new sagscroller({
	id:'mysagscroller2',
	mode: 'auto',
	pause: 2500,
	animatespeed: 400 //<--no comma following last option
})
     function show(id)
     {
		
        if(document.getElementById(id).style.display == 'none')
        {
              document.getElementById(id).style.display='inline';
			  document.getElementById(id).select();
        }
		else if(document.getElementById(id).style.display == 'inline')
        {
              document.getElementById(id).style.display='none';
        } 
     }
    </script>    
</head>
<body>
<!--------------Header--------------->
<header> 
  <div id="logo"><a href="#"><img src="./images/logo.png"/></a></div>
</header>
<!--------------Navigation--------------->
<nav>
		<!--<ul class="menu">
    	<li><a href="index.html">About TOP</a></li>
		<li><a href="aboutus.html">About us</a></li>
		<li><a href="contact.html">Contact</a></li>
	</ul>-->
	<div class="minimenu"><div>INDEX</div>
		<select onchange="location=this.value">
        <option></option>
			<option value="home.html">Home</option>
			<option value="Amisulpride.html">Amisulpride</option>
			<option value="DER.html">Divalproex extended release</option>
			<option value="MBD.html">MetS with bipolar disorder</option>
			<option value="EP.html">Escitalopram</option>
			<option value="ZER.html">Zolpidem extended release</option>
            <option value="SCL.html">Scales</option>
			<option value="GDL.html">Guidelines</option>
			<option value="JC.html">Journal scans</option>
			<option value="CN.html">Conference news</option>
            <option value="PMS.html">Psychiatry medical app</option>
            <option value="BR.html">Book review</option> 
		</select>
	</div>
</nav>
<!--------------Content--------------->
<section id="content">
	<div id="main-content">
		<article>
			<div class="heading">
				<div style="background-color:#bb8e2c; padding:10px; border-radius:10px;"><h11a>Rising burden of MetS in Indians with
bipolar disorder</h11a></div>
				<div class="info"> by Medeka Health | November 01, 2013</div>
			</div>Metabolic syndrome (MetS) is considered to be a
significant problem in both psychiatry and public
health. It is a combination of metabolic factors
(atherogenic dyslipidemia, elevated blood pressure
and glucose, prothrombotic and proinflammatory
states) that, when associated together, increase
the risk of cardiovascular disease and diabetes by
2-folds and 5-folds respectively.<sup>1</sup> The prevalence of
MetS is increasing globally and varies with sex, age,
and ethnicity.<sup>2</sup> In the West, the prevalence of MetS
ranges from 16.7 to 67% in patients with bipolar
disorder (BD). Further, these rates are higher
in patients treated with atypical antipsychotics.
Other factors contributing to MetS could be the
higher activation of the stress pathway through the
hypothalamic–pituitary axis and genetic factors.
Very few studies from India have evaluated the
burden of MetS in patients with BD.<sup>3</sup><br>
<br>
<p>
  <h12d>Prevalence of metabolic
    syndrome is high in
    Indians with bipolar
    disorder</h12d>          
<div class="content">
			  <ul><h14>
              <li style="list-style-type:square; color:#bb8e2c; font-size:16px">
              Malhotra et al. study </li>
              A prospective, observational study assessed the
prevalence of MetS in 161 patients with either BD
(n=97) or schizophrenia (n=64). Mean duration
of illness in BD patients was 122 months and
most of them were on either lithium or valproate.
All patients were assessed for metabolic profiles
at baseline and at 3 and 6 months respectively.
Prevalence of MetS in BD patients increased from
40 to 48% over the 6 months. Increase in the
prevalence of MetS in BD patients was over 4%
in 3 months and 8% in 6 months(<a onMouseOver="cursor:hand;"  onClick="javascript:show('vk');"><font color="#bb8e2c">Table 1</font></a>).
            <div id="vk" runat="server" style="display: none; text-align: justify; font-size:13px;">
<a  onMouseOver="cursor:hand;"  onClick="javascript:show('vk');"> <p> <img src="images/MBDtable1.gif" alt="Table 1"></p></a></div> The
prevalence rate was lower when patients with preexisting
hypertension and diabetes were excluded
(<a onMouseOver="cursor:hand;"  onClick="javascript:show('vk1');"><font color="#bb8e2c">Table 1</font></a>).
            <div id="vk1" runat="server" style="display: none; text-align: justify; font-size:13px;">
<a  onMouseOver="cursor:hand;"  onClick="javascript:show('vk1');"> <p> <img src="images/MBDtable1.gif" alt="Table 1"></p></a></div>
             Abnormal waist circumference contributed
to a higher prevalence of MetS. Further, the risk
of MetS was higher in BD patients with partial
MetS (those who fulfilled 1 or 2 criteria of MetS;<a onMouseOver="cursor:hand;"  onClick="javascript:show('vk2');"><font color="#bb8e2c"> Table 1</font></a>).
            <div id="vk2" runat="server" style="display: none; text-align: justify; font-size:13px;">
<a  onMouseOver="cursor:hand;"  onClick="javascript:show('vk2');"> <p> <img src="images/MBDtable1.gif" alt="Table 1"></p></a></div> Hence, early screening, regular
monitoring, and early institution of preventive
measures may prevent the occurrence of MetS,
especially in BD patients with partial MetS.<sup>4</sup>
<li style="list-style-type:square; color:#bb8e2c; font-size:16px">Grover et al. study</li>A total of 200 patients with BD were used to assess
the prevalence of MetS. Patients were diagnosed to
have MetS using International Diabetes Federation
(IDF) and modified National Cholesterol Education
Program Adult Treatment Panel III (NCEP ATPIII)
criteria. Most of the patients were on mood
stabilizers (either lithium [n=94] or valproate
[n=86]) and more than half of them were also on
antipsychotic medication (olanzapine, n=70).
<p>Out of 200, 80 (40%) patients fulfilled the IDF
criteria, and 82 (41%) patients fulfilled the NCEP
ATP-III criteria for MetS. Among the various
components of MetS, increased waist circumference
(70.1%) was the most common abnormality seen.
This was followed by increased blood pressure
(44.5%), increased triglyceride levels (42%),
and low high density lipoprotein levels (41.5%).
Prevalence of MetS did not vary between males
and females. Patients with MetS were mostly older,
had longer duration of illness, and also had higher
body mass index (BMI). Patients receiving 2 mood
stabilizers were at a higher risk of MetS than those
receiving 1 or none. Prediction analysis found that
age >35 years, and BMI >25 could predict MetS.<sup>5</sup></p>
</h14>
</ul>
 </div>
 <div id="top4">
		<section>
		  <div class="heading">
			<div class="content">
				<ul> <li style="color:#CCC">Prevalence of metabolic
syndrome is high in
Indians with bipolar
disorder
             </li>
             <li><a href="MBD-II.html">Conclusion</a></li>
             <li><a href="MBD-III.html">References</a></li>

</ul>
                </div></section></div>
		<img src="images/MDBadd.gif" width="575" height="148"/>
      </article>
	</div>
	<div id="sidebar">
		<section>
		  <div class="heading">
	    <h2>Contents</h2></div>
			<div class="content">
				<ul>
					<li><a href="Amisulpride.html">Amisulpride</a></li>
					<li><a href="DER.html">Divalproex extended release</a></li>
					<li><a href="MBD.html">MetS with bipolar disorder</a></li>
					<li><a href="EP.html">Escitalopram</a></li>
					<li><a href="ZER.html">Zolpidem extended release</a></li>
					<li><a href="SCL.html">Scales</a></li>
                    <li><a href="GDL.html">Guidelines</a></li>
                    <li><a href="JC.html">Journal scans</a></li>
                    <li><a href="CN.html">Conference news</a></li>
                  <li><a href="PMS.html">Psychiatry medical app</a></li>
                    <li><a href="BR.html">Book review</a></li>
				</ul>
			</div>
		</section>
	  <section>
			<div class="heading"><h2>Archives</h2></div>
			<div class="content">
				<ul>
					<li><a href="../Issue_4/index.html">Present Issue</a></li>
					<li><a href="">Previous Issue</a></li>
				</ul>
			</div>
		</section>
	</div>
	<div class="clear"></div>
</section>
<!--------------Footer--------------->
<footer>
	<p>Copyright © 2013 Medekahealth - All rights reserved. | Design by: MedekaHealth</p>
</footer>
</body></html>